Prognostic factors (with a β2-microglobulin cutoff of 4 mg/L)
| Parameter . | Univariate analysis . | Multivariate analysis . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| Age (n = 697) | 1.03 (1.02-1.05) | < .0001 | 1.03 (1.01-1.05) | < .001 |
| β2-microglobulin ≥ 4 vs < 4 | 2.02 (1.65-2.47) | < .0001 | 2.26 (1.74-2.93) | < .0001 |
| t(4,14) positive vs negative | 2.24 (1.72-2.92) | < .0001 | 2.63 (1.88-3.67) | < .0001 |
| del(17p) ≥ 60 vs < 60 | 2.57 (1.88-3.50) | < .0001 | 2.51 (1.71-3.68) | < .0001 |
| del13 > 0 vs 0 | 1.63 (1.34-1.97) | < .0001 | 1.39 (1.05-1.83) | .021 |
| t(14,16) positive vs negative | 1.28 (0.82-2.01) | .281 | 1.24 (0.76-2.02) | .388 |
| Parameter . | Univariate analysis . | Multivariate analysis . | ||
|---|---|---|---|---|
| HR (95% CI) . | P . | HR (95% CI) . | P . | |
| Age (n = 697) | 1.03 (1.02-1.05) | < .0001 | 1.03 (1.01-1.05) | < .001 |
| β2-microglobulin ≥ 4 vs < 4 | 2.02 (1.65-2.47) | < .0001 | 2.26 (1.74-2.93) | < .0001 |
| t(4,14) positive vs negative | 2.24 (1.72-2.92) | < .0001 | 2.63 (1.88-3.67) | < .0001 |
| del(17p) ≥ 60 vs < 60 | 2.57 (1.88-3.50) | < .0001 | 2.51 (1.71-3.68) | < .0001 |
| del13 > 0 vs 0 | 1.63 (1.34-1.97) | < .0001 | 1.39 (1.05-1.83) | .021 |
| t(14,16) positive vs negative | 1.28 (0.82-2.01) | .281 | 1.24 (0.76-2.02) | .388 |
HR indicates hazard ratio; and CI, confidence interval.